Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Open | $127.180 |
Close | $127.570 |
Volume / Avg. | 6.552M / 8.205M |
Day Range | 126.760 - 127.730 |
52 Wk Range | 99.140 - 133.100 |
Market Cap | $321.695B |
P/E Ratio | 141.678 |
Dividend Yield | 2.420% |
Exchange | NYSE |
RSI | 0 |
Short Interest | 0.77% |
Days to Cover | 2.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Truist Securities on Friday, April 26, 2024. The analyst firm set a price target for 143.00 expecting MRK to rise to within 12 months (a possible 12.60% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $127 last updated May 6, 2024 at 6:52 PM EDT.
A quarterly cash dividend of $0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on April 5, 2024 to stockholders of record on March 14, 2024.
Merck & Co’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.